Chris Radoux

Chris Radoux is the Director of Structure-based Technology at Recursion, a role they have held since 2024. With over five years of experience in Python for drug discovery, Chris previously worked as a Senior Structural Bioinformatician and in various leadership positions at Exscientia. They earned a PhD in Biochemistry from the University of Cambridge and a BSc in Chemistry from the University of Sussex. Prior to their current position, Chris was a Protein Computational Scientist at the European Bioinformatics Institute and gained experience at AstraZeneca as a Computational Chemistry Sandwich Student.